TY - JOUR
T1 - Building a vertically integrated genomic learning health system
T2 - The biobank at the Colorado Center for Personalized Medicine
AU - Wiley, Laura K.
AU - Shortt, Jonathan A.
AU - Roberts, Emily R.
AU - Lowery, Jan
AU - Kudron, Elizabeth
AU - Lin, Meng
AU - Mayer, David
AU - Wilson, Melissa
AU - Brunetti, Tonya M.
AU - Chavan, Sameer
AU - Phang, Tzu L.
AU - Pozdeyev, Nikita
AU - Lesny, Joseph
AU - Wicks, Stephen J.
AU - Moore, Ethan T.
AU - Morgenstern, Joshua L.
AU - Roff, Alanna N.
AU - Shalowitz, Elise L.
AU - Stewart, Adrian
AU - Williams, Cole
AU - Edelmann, Michelle N.
AU - Hull, Madelyne
AU - Patton, J. Tacker
AU - Axell, Lisen
AU - Ku, Lisa
AU - Lee, Yee Ming
AU - Jirikowic, Jean
AU - Tanaka, Anna
AU - Todd, Emily
AU - White, Sarah
AU - Peterson, Brett
AU - Hearst, Emily
AU - Zane, Richard
AU - Greene, Casey S.
AU - Mathias, Rasika
AU - Coors, Marilyn
AU - Taylor, Matthew
AU - Ghosh, Debashis
AU - Kahn, Michael G.
AU - Brooks, Ian M.
AU - Aquilante, Christina L.
AU - Kao, David
AU - Rafaels, Nicholas
AU - Crooks, Kristy R.
AU - Hess, Steve
AU - Barnes, Kathleen C.
AU - Gignoux, Christopher R.
N1 - Publisher Copyright:
© 2023 The Authors
PY - 2024/1/4
Y1 - 2024/1/4
N2 - Precision medicine initiatives across the globe have led to a revolution of repositories linking large-scale genomic data with electronic health records, enabling genomic analyses across the entire phenome. Many of these initiatives focus solely on research insights, leading to limited direct benefit to patients. We describe the biobank at the Colorado Center for Personalized Medicine (CCPM Biobank) that was jointly developed by the University of Colorado Anschutz Medical Campus and UCHealth to serve as a unique, dual-purpose research and clinical resource accelerating personalized medicine. This living resource currently has more than 200,000 participants with ongoing recruitment. We highlight the clinical, laboratory, regulatory, and HIPAA-compliant informatics infrastructure along with our stakeholder engagement, consent, recontact, and participant engagement strategies. We characterize aspects of genetic and geographic diversity unique to the Rocky Mountain region, the primary catchment area for CCPM Biobank participants. We leverage linked health and demographic information of the CCPM Biobank participant population to demonstrate the utility of the CCPM Biobank to replicate complex trait associations in the first 33,674 genotyped individuals across multiple disease domains. Finally, we describe our current efforts toward return of clinical genetic test results, including high-impact pathogenic variants and pharmacogenetic information, and our broader goals as the CCPM Biobank continues to grow. Bringing clinical and research interests together fosters unique clinical and translational questions that can be addressed from the large EHR-linked CCPM Biobank resource within a HIPAA- and CLIA-certified environment.
AB - Precision medicine initiatives across the globe have led to a revolution of repositories linking large-scale genomic data with electronic health records, enabling genomic analyses across the entire phenome. Many of these initiatives focus solely on research insights, leading to limited direct benefit to patients. We describe the biobank at the Colorado Center for Personalized Medicine (CCPM Biobank) that was jointly developed by the University of Colorado Anschutz Medical Campus and UCHealth to serve as a unique, dual-purpose research and clinical resource accelerating personalized medicine. This living resource currently has more than 200,000 participants with ongoing recruitment. We highlight the clinical, laboratory, regulatory, and HIPAA-compliant informatics infrastructure along with our stakeholder engagement, consent, recontact, and participant engagement strategies. We characterize aspects of genetic and geographic diversity unique to the Rocky Mountain region, the primary catchment area for CCPM Biobank participants. We leverage linked health and demographic information of the CCPM Biobank participant population to demonstrate the utility of the CCPM Biobank to replicate complex trait associations in the first 33,674 genotyped individuals across multiple disease domains. Finally, we describe our current efforts toward return of clinical genetic test results, including high-impact pathogenic variants and pharmacogenetic information, and our broader goals as the CCPM Biobank continues to grow. Bringing clinical and research interests together fosters unique clinical and translational questions that can be addressed from the large EHR-linked CCPM Biobank resource within a HIPAA- and CLIA-certified environment.
KW - biobanking
KW - electronic health records
KW - learning health system
KW - pharmacogenomics
KW - precision medicine
UR - http://www.scopus.com/inward/record.url?scp=85181126917&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2023.12.001
DO - 10.1016/j.ajhg.2023.12.001
M3 - Article
C2 - 38181729
AN - SCOPUS:85181126917
SN - 0002-9297
VL - 111
SP - 11
EP - 23
JO - American journal of human genetics
JF - American journal of human genetics
IS - 1
ER -